Postes actifs de Roger Léger
Sociétés | Poste | Début | Fin |
---|---|---|---|
Indel Therapeutics, Inc.
Indel Therapeutics, Inc. BiotechnologyHealth Technology Indel Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of antibiotics to address the health crisis caused by antibiotics resistance. The firm’s programs are based on Indel's paradigm-changing antimicrobial drug discovery platform that has opened drug targets for the treatment of bacterial and parasitic infections, and potentially, fungal and viral infections. The company was founded by Malcolm C. Kendall in 2008 and is headquartered in Vancouver, Canada.^ ^ | Corporate Officer/Principal | 30/10/2012 | - |
Directeur Technique/Scientifique/R&D | 29/04/2011 | 30/10/2012 |
Historique de carrière de Roger Léger
Anciens postes connus de Roger Léger
Sociétés | Poste | Début | Fin |
---|---|---|---|
Ulysses Pharmaceuticals Pvt Ltd.
Ulysses Pharmaceuticals Pvt Ltd. Pharmaceuticals: OtherHealth Technology Ulysses Pharmaceuticals Pvt Ltd. provides homeopathic modern medicines. It engages in the discovery and development of novel and safe antimicrobial agents for the treatment of severe and recurrent infections occurring in human. The company was founded in July 2001 and is headquartered in Kolkata, India. | Fondateur | 01/07/2001 | - |
ConjuChem Biotechnologies, Inc.
ConjuChem Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology ConjuChem Biotechnologies, Inc. develops peptide based pharmaceuticals. Its peptide products are used to treat diseases such as congestive heart failure, diabetes, HIV/AIDS and human growth deficiencies. ConjuChem Biotechnologies is a research and development company that develops technology that binds peptides to albumin in order to extend the half life of drugs from minutes to days. The company was founded on August 25, 2009 and is headquartered in Montréal, Canada. | Corporate Officer/Principal | - | - |
Essential Therapeutics, Inc.
Essential Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Essential Therapeutics, Inc. manufactures pharmaceutical goods for viral and fungal infections | Corporate Officer/Principal | - | - |
Ulysses Pharmaceuticals Products, Inc.
Ulysses Pharmaceuticals Products, Inc. Pharmaceuticals: MajorHealth Technology Ulysses Pharmaceuticals discovers and develops antibiotics for empiric monotherapy to control resistant bacterial infections. The company was founded in December 2001 by Suzanne Chamberland, Roger Léger, and François Malouin and is headquartered in Sherbrooke, Canada | Directeur Technique/Scientifique/R&D | - | - |
Statistiques
Internationale
Canada | 4 |
Etats-Unis | 2 |
Inde | 2 |
Opérationnelle
Corporate Officer/Principal | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Founder | 1 |
Sectorielle
Health Technology | 6 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 5 |
---|---|
Essential Therapeutics, Inc.
Essential Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Essential Therapeutics, Inc. manufactures pharmaceutical goods for viral and fungal infections | Health Technology |
Ulysses Pharmaceuticals Products, Inc.
Ulysses Pharmaceuticals Products, Inc. Pharmaceuticals: MajorHealth Technology Ulysses Pharmaceuticals discovers and develops antibiotics for empiric monotherapy to control resistant bacterial infections. The company was founded in December 2001 by Suzanne Chamberland, Roger Léger, and François Malouin and is headquartered in Sherbrooke, Canada | Health Technology |
ConjuChem Biotechnologies, Inc.
ConjuChem Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology ConjuChem Biotechnologies, Inc. develops peptide based pharmaceuticals. Its peptide products are used to treat diseases such as congestive heart failure, diabetes, HIV/AIDS and human growth deficiencies. ConjuChem Biotechnologies is a research and development company that develops technology that binds peptides to albumin in order to extend the half life of drugs from minutes to days. The company was founded on August 25, 2009 and is headquartered in Montréal, Canada. | Health Technology |
Indel Therapeutics, Inc.
Indel Therapeutics, Inc. BiotechnologyHealth Technology Indel Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of antibiotics to address the health crisis caused by antibiotics resistance. The firm’s programs are based on Indel's paradigm-changing antimicrobial drug discovery platform that has opened drug targets for the treatment of bacterial and parasitic infections, and potentially, fungal and viral infections. The company was founded by Malcolm C. Kendall in 2008 and is headquartered in Vancouver, Canada.^ ^ | Health Technology |
Ulysses Pharmaceuticals Pvt Ltd.
Ulysses Pharmaceuticals Pvt Ltd. Pharmaceuticals: OtherHealth Technology Ulysses Pharmaceuticals Pvt Ltd. provides homeopathic modern medicines. It engages in the discovery and development of novel and safe antimicrobial agents for the treatment of severe and recurrent infections occurring in human. The company was founded in July 2001 and is headquartered in Kolkata, India. | Health Technology |
- Bourse
- Insiders
- Roger Léger
- Expérience